Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Galecto, Inc.

Equities

GLTO

US36322Q1076

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-20 EDT 		5-day change 1st Jan Change
0.6359 USD +2.38% Intraday chart for Galecto, Inc. -6.50% -11.68%
05-01 Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab CI
04-29 Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GALECTO, INC. Stock Galecto, Inc.
 16.84M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.87B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Charts Galecto, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW